© Reuters. FILE PHOTO-The company logo for Haleon and the trading info is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., July 20, 2022. REUTERS/Brendan McDermid/file photo
(Reuters) -Haleon, the world’s biggest standalone consumer health business, is planning to cut hundreds of roles in the UK and potentially thousands worldwide, the Guardian reported on Thursday.
The company behind the Sensodyne toothpaste and Advil painkillers was spun off from GSK last year and has more than 24,000 staff globally.
Staff were informed about the redundancies this week in a series of meetings and a consultation process, which started on Wednesday, would close on Aug. 25, the report said.
Those who are laid off are expected to leave Haleon in September, according to the report.
Haleon did not immediately respond to Reuters’ request for a comment.